How to buy TELA Bio stock | $12.59

TELA Bio Inc is a medical devices business based in the US. TELA Bio shares (TELA) are listed on the NASDAQ and all prices are listed in US Dollars. TELA Bio employs 108 staff and has a trailing 12-month revenue of around 0.00.

TELA Bio stock price (NASDAQ: TELA)

Use our graph to track the performance of TELA stocks over time.

TELA Bio shares at a glance

• Key figures

Information last updated 2021-10-17.

Latest market close	$12.59
52-week range	$11.60 - $18.00
50-day moving average	$12.88
200-day moving average	$13.76
Wall St. target price	$20.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-2.21

Buy TELA Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy TELA Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TELA Bio price performance over time

Historical closes compared with the close of $12.59 from 2021-10-21

1 week (2021-10-15)	-0.08%
1 month (2021-09-23)	-2.55%
3 months (2021-07-23)	-17.50%
6 months (2021-04-23)	-6.74%

1 year (2020-10-23)	-25.90%
2 years (2019-10-19)	N/A
3 years (2018-10-19)	N/A
5 years (2016-10-19)	N/A

TELA Bio financials

Revenue TTM	$24.4 million
Gross profit TTM	$11.5 million
Return on assets TTM	-20.57%
Return on equity TTM	-64.83%
Profit margin	-130.59%
Book value	$2.42
Market capitalisation	$182.3 million

TTM: trailing 12 months

Shorting TELA Bio shares

There are currently 80,003 TELA Bio shares held short by investors – that's known as TELA Bio's "short interest". This figure is 5.6% up from 75,788 last month.

There are a few different ways that this level of interest in shorting TELA Bio shares can be evaluated.

TELA Bio's "short interest ratio" (SIR)

TELA Bio's "short interest ratio" (SIR) is the quantity of TELA Bio shares currently shorted divided by the average quantity of TELA Bio shares traded daily (recently around 14235.409252669). TELA Bio's SIR currently stands at 5.62. In other words for every 100,000 TELA Bio shares traded daily on the market, roughly 5620 shares are currently held short.

However TELA Bio's short interest can also be evaluated against the total number of TELA Bio shares, or, against the total number of tradable TELA Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TELA Bio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 TELA Bio shares in existence, roughly 10 shares are currently held short) or 0.0168% of the tradable shares (for every 100,000 tradable TELA Bio shares, roughly 17 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against TELA Bio.

Find out more about how you can short TELA Bio stock.

TELA Bio share dividends

We're not expecting TELA Bio to pay a dividend over the next 12 months.

TELA Bio overview

TELA Bio, Inc. , a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. .

Frequently asked questions

What percentage of TELA Bio is owned by insiders or institutions?
Currently 7.328% of TELA Bio shares are held by insiders and 89.615% by institutions. How many people work for TELA Bio?
Latest data suggests 108 work at TELA Bio. When does the fiscal year end for TELA Bio?
TELA Bio's fiscal year ends in December. Where is TELA Bio based?
TELA Bio's address is: 1 Great Valley Parkway, Malvern, PA, United States, 19355 What is TELA Bio's ISIN number?
TELA Bio's international securities identification number is: US8723811084 What is TELA Bio's CUSIP number?
TELA Bio's Committee on Uniform Securities Identification Procedures number is: 872381108